Vaxcyte Total Long Term Liabilities 2019-2024 | PCVX

Vaxcyte total long term liabilities for the quarter ending June 30, 2024 were $0.018B, a 98.2% increase year-over-year.

  • Vaxcyte total long term liabilities for 2023 were $0.022B, a 83.65% increase from 2022.
  • Vaxcyte total long term liabilities for 2022 were $0.012B, a 3.77% increase from 2021.
  • Vaxcyte total long term liabilities for 2021 were $0.012B, a 9410.66% increase from 2020.

Vaxcyte Total Long Term Liabilities 2019-2024 | PCVX

  • Vaxcyte total long term liabilities for 2023 were $0.022B, a 83.65% increase from 2022.
  • Vaxcyte total long term liabilities for 2022 were $0.012B, a 3.77% increase from 2021.
  • Vaxcyte total long term liabilities for 2021 were $0.012B, a 9410.66% increase from 2020.